53,258 Astrana Health, Inc. $ASTH Shares Sold by Royce & Associates LP

Royce & Associates LP lessened its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 11.3% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 419,222 shares of the company’s stock after selling 53,258 shares during the period. Royce & Associates LP owned approximately 0.75% of Astrana Health worth $14,912,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Dimensional Fund Advisors LP increased its position in Astrana Health by 12.5% during the first quarter. Dimensional Fund Advisors LP now owns 1,368,079 shares of the company’s stock valued at $33,545,000 after acquiring an additional 152,267 shares during the last quarter. Diamond Hill Capital Management LLC Investment Advisor bought a new stake in shares of Astrana Health in the 2nd quarter worth about $22,088,000. Bank of America Corp DE lifted its holdings in shares of Astrana Health by 13.3% in the 1st quarter. Bank of America Corp DE now owns 574,729 shares of the company’s stock worth $14,092,000 after acquiring an additional 67,628 shares during the last quarter. Bank of New York Mellon Corp bought a new stake in shares of Astrana Health in the 2nd quarter worth about $10,902,000. Finally, Principal Financial Group Inc. boosted its stake in shares of Astrana Health by 15.7% during the 1st quarter. Principal Financial Group Inc. now owns 265,948 shares of the company’s stock worth $6,521,000 after purchasing an additional 36,150 shares during the period. 52.77% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently commented on ASTH shares. Barclays upped their price target on shares of Astrana Health from $50.00 to $53.00 and gave the company an “overweight” rating in a report on Friday, August 7th. Weiss Ratings restated a “hold (c)” rating on shares of Astrana Health in a research report on Thursday, August 27th. Truist Financial boosted their target price on Astrana Health from $47.00 to $55.00 and gave the company a “buy” rating in a research report on Monday, August 10th. Oppenheimer initiated coverage on Astrana Health in a report on Tuesday, September 15th. They set an “outperform” rating and a $53.00 price objective for the company. Finally, Needham & Company LLC upped their price objective on Astrana Health from $41.00 to $45.00 and gave the company a “buy” rating in a research report on Friday, November 6th. Eight equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $50.38.

View Our Latest Analysis on Astrana Health

Astrana Health Price Performance

Astrana Health stock opened at $32.87 on Tuesday. The stock has a market cap of $1.83 billion, a price-to-earnings ratio of 30.72 and a beta of 1.18. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.25 and a quick ratio of 1.23. Astrana Health, Inc. has a 1 year low of $18.08 and a 1 year high of $51.60. The firm has a 50-day moving average of $36.30 and a two-hundred day moving average of $34.24.

Astrana Health (NASDAQ:ASTH – Get Free Report) last issued its earnings results on Thursday, November 5th. The company reported $0.71 EPS for the quarter, topping analysts’ consensus estimates of $0.46 by $0.25. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. Astrana Health had a net margin of 1.36% and a return on equity of 11.57%. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period last year, the company posted $0.01 earnings per share. On average, research analysts forecast that Astrana Health, Inc. will post 1.36 earnings per share for the current year.

Astrana Health Profile

(Free Report)

Astrana Health, Inc. is a physician-centric healthcare company that coordinates and delivers care through a network of primary care physicians, specialists and other providers. Its services include primary and specialty care, care coordination, hospital-based care and technology-enabled population health management. The company works with health plans and provider groups under value-based care arrangements, which emphasize coordinating care and managing patients’ health needs across different settings.

Further Reading

Want to see what other hedge funds are holding ASTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astrana Health, Inc. (NASDAQ:ASTH – Free Report).

Institutional Ownership by Quarter for Astrana Health (NASDAQ:ASTH)

Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.